Back
CapitaLand India Trust Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
54
ACNDF
CapitaLand India Trust
Last Price:
$0.93
Seasonality Move:
4.53%
Buy
64
LYEL
Lyell Immunopharma, Inc.
Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
54
CapitaLand India Trust (ACNDF)
is a Buy
Is CapitaLand India Trust a Buy, Sell or Hold?
-
The current CapitaLand India Trust [ACNDF] share price is $0.93. The Score for ACNDF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
ACNDF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACNDF Stock Price Chart
What is CapitaLand India Trust's stock price today?
-
The CapitaLand India Trust share price today is $0.93The current trend is relatively stagnant and ACNDF is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $37.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.
ACNDF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 52.04 | Buy |
| Chaikin Money Flow: | -2544 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.9 - 0.94) | Buy |
| Bollinger Bands (100): | (0.89 - 0.93) | Buy |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.08 | Buy |
| Relative Strength Index (14 RSI): | 79.16 | Buy |
| Chaikin Money Flow: | -97373 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.11 - 32.35) | Buy |
| Bollinger Bands (100): | (10.77 - 23.75) | Buy |
ACNDF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.94 | Sell |
| 20-day SMA: | 0.92 | Buy |
| 50-day SMA: | 0.92 | Buy |
| 200-day SMA: | 0.84 | Buy |
| 8-day EMA: | 0.94 | Sell |
| 20-day EMA: | 0.93 | Buy |
| 50-day EMA: | 0.92 | Buy |
| 200-day EMA: | 0.86 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.51 | Buy |
| 20-day SMA: | 28.33 | Buy |
| 50-day SMA: | 21.67 | Buy |
| 200-day SMA: | 13.52 | Buy |
| 8-day EMA: | 33.02 | Buy |
| 20-day EMA: | 28.99 | Buy |
| 50-day EMA: | 23.45 | Buy |
| 200-day EMA: | 17.42 | Buy |
CapitaLand India Trust Earnings Growth & ACNDF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
CapitaLand India Trust Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||